Our Regulatory Strategy service helps pharmaceutical companies navigate the complex landscape of global drug approvals. We provide real-time regulatory intelligence covering FDA, EMA, CDSCO, PMDA, and 50+ other regulatory authorities. Our team monitors submission timelines, approval trends, and regulatory policy changes to help you optimize your regulatory pathway.
How our regulatory strategy service delivers value to your organization.
Real-time monitoring of 50+ regulatory authorities including FDA, EMA, CDSCO, PMDA, NMPA, and MHRA.
Strategic guidance on submission timing, content requirements, and agency interactions to maximize approval probability.
Automated alerts on regulatory policy changes, guidance updates, and new requirements that impact your pipeline.
Historical approval rate analysis by therapeutic area, submission type, and regulatory pathway to inform your strategy.
Comprehensive deliverables that provide actionable intelligence for your team.
A structured methodology that delivers results in four phases.
Evaluate your asset against current regulatory requirements across target markets.
Identify the most efficient regulatory pathway considering expedited programs and special designations.
Develop a detailed submission timeline with agency interaction points and content requirements.
Track regulatory changes and provide updates on agency expectations and policy shifts.
We cover 50+ regulatory authorities globally, including FDA, EMA, CDSCO, PMDA, NMPA, MHRA, Health Canada, TGA, and ANVISA.
Yes, we identify opportunities for Fast Track, Breakthrough Therapy, Priority Review, PRIME, and other expedited programs based on your asset profile.
Yes, our regulatory intelligence covers biosimilar pathways including FDA, EMA, and WHO biosimilar guidelines.
Track global drug pipelines across 190+ markets with phase progression analysis, competitive landscaping, and predictive scoring.
Learn moreDetailed market sizing, forecasting, and competitor positioning to identify white space and launch opportunities.
Learn moreSequenced launch planning across markets with pricing, access, and competitive positioning tailored to each region.
Learn moreConnect with our team to discuss how our regulatory strategy service can support your goals.
Schedule a Consultation